|
|
|
|
| LEADER |
01495naa a2200361 i 4500 |
| 001 |
NSK01001090757 |
| 003 |
HR-ZaNSK |
| 005 |
20220204155019.0 |
| 007 |
ta |
| 008 |
210216s2018 ci a | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)001090757
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 615
|2 2011
|
| 080 |
1 |
|
|a 54
|2 2011
|
| 100 |
1 |
|
|a Shehzadi, Naureen
|4 aut
|9 HR-ZaNSK
|
| 245 |
1 |
0 |
|a Reverse-phase chromatographic determination and intrinsic stability behavior of 5-[(4-chlorophenoxy)methyl]- -1,3,4-oxadiazole-2-thiol /
|c Naureen Shehzadi, Khalid Hussain, Muhammad Islam, Nadeem Irfan Bukhari, Muhammad Tanveer Khan, Muhammad Salman, Sabahat Zahra Siddiqui, Aziz-Ur Rehman, Muhammad Athar Abbasi.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 20 jed.
|
| 653 |
|
0 |
|a Novi lijekovi
|a Oksadiazol
|a Tiol
|a Kromatografske metode
|a Stabilnost
|
| 700 |
1 |
|
|a Hussain, Khalid
|4 aut
|
| 700 |
1 |
|
|a Islam, Muhammad
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Irfan Bukhari, Nadeem
|4 aut
|
| 700 |
1 |
|
|a Khan, Muhammad Tanveer
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Salman, Muhammad
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Siddiqui, Sabahat Zahra
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Rehman, Aziz-Ur
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Abbasi, Muhammad Athar
|4 aut
|9 HR-ZaNSK
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 68 (2018), 4 ; str. 409-424
|w nsk.(HR-ZaNSK)000054908
|
| 981 |
|
|
|b B08/18
|
| 998 |
|
|
|b gtao2102
|
| 856 |
4 |
1 |
|u https://hrcak.srce.hr/202261
|y Elektronička verzija članka
|